The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease.

The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q34048075
Treatment of inflammatory bowel disease in childhood: best available evidence.The anti-inflammatory activity of a novel fused-cyclopentenone phosphonate and its potential in the local treatment of experimental colitis.Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.Novel drug delivery strategies for the treatment of inflammatory bowel disease.Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.Usefulness of sulfasalazine for patients with refractory-ulcerative colits.The efficacy of the combination therapy with oral and topical mesalazine for patients with the first episode of radiation proctitis.Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases.Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.Use of the 'nutriceutical', bovine colostrum, for the treatment of distal colitis: results from an initial study.Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation.Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease.Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis.5-aminosalicylic acid release from a new controlled-release mesalazine formulation during gastrointestinal transit in healthy volunteers.
P2860

The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease.

Item
http://www.wikidata.org/entity/Q34048075
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@ast
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@en
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@nl
type
label
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@ast
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@en
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@nl
prefLabel
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@ast
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@en
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
The role of aminosalicylates a ...... ic inflammatory bowel disease.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P921